Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: Are They Different from Those with Common <i>EGFR</i> Mutations?

Approximately 10% of the epidermal growth factor receptor (<i>EGFR</i>) mutations in non-small-cell lung cancer (NSCLC) are uncommon <i>EGFR</i> mutations. Although the efficacy of second (2G) or third generation (3G) <i>EGFR</i> tyrosine kinase inhibitors (EGFR-T...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2020-10-01
Colecção:Biology
Assuntos:
uncommon <i>EGFR</i> mutation
EGFR-TKIs
T790M
overall survival
progression-free survival
Acesso em linha:https://www.mdpi.com/2079-7737/9/10/326
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados